FDA User Fees Could Be Freed From Sequester As Senate Drafts Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Senators working on legislation to fund FDA in fiscal 2014 will try to address all user fees, not just those collected in the fiscal year that begins Oct. 1, Arkansas Democrat Mark Pryor, chairman of the appropriations subcommittee responsible for the bill, says.
You may also be interested in...
FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted
Rep. Farr says Congressional Budget Office scoring problems could not be overcome, meaning FY 2013 FDA user fees lost to sequester may not be recovered, but amendment will be proposed to ensure FY 2014 fees are not lost in the upcoming appropriations bill.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.